Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content. The visible elements indicate an access block preventing viewing trial details.
    Difference
    19%
    Check dated 2026-09-21T20:38:13.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:33:23.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 500-style error page with an HTML structure indicating the requested study record is temporarily unavailable.
    Difference
    18%
    Check dated 2026-08-10T11:50:42.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor site update that does not alter the study information.
    Difference
    0.1%
    Check dated 2026-07-27T05:53:11.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3 in the footer, updating from v3.6.2 to v3.6.3. This indicates a maintenance/version update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-05T11:16:30.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a small site update without changing the study details or related content.
    Difference
    0.1%
    Check dated 2026-06-28T08:17:54.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.